Pulled line, started another, wrote incident report, talked with DON, and of course, since this was an incident involving one of the pets, was told "just do not let it happen again.
I found the mess, I did not create the mess, I had been off and this was a new resident to me. Even in resident who have ports and other devices, this facility wants an Act of God to use them.
Just another reason why I am looking for a new job. Specializes in Hospital Education Coordinator. Feb 19, The Infusion Nurse Society standards indicate that meds with a high pH or very low pH should not be infused peripherally.
That would be pH 9. Feb 24, I remember a time when giving Vanco was a major event and it was a medication that was rarely used.
At that time, it had to be infused via a central line. I frankly don't like infusing it via the PIV route. Has 6 years experience. When I was in medicine we would generally plan to get a PICC placed if a patient was found to need Vanco by ID--they were usually the docs seeing these infections that were resistant to other ABX-- they would tell us it was okay to give a few doses via a peripheral line but generally the nurses would be nagging the docs saying--Hey Clinicians considering drug administration via this VAD should review the chemical properties of the drug under consideration from reputable resources eg, prescribing information to compare them with the guidance above.
Nonetheless, a review of literature of known vesicants and drugs reported to cause vascular injury or extravasation indicates some drugs that may present higher risk when administered via midline catheter.
For example, many cytotoxic agents ie, chemotherapy are considered vesicants and should not be administered via midline catheters according to INS standards. One drug that has generated controversy regarding its appropriateness for administration via midline catheter is vancomycin. Based on the range of pH values generally considered appropriate for midline administration, vancomycin would be excluded because of its pH of 4. Furthermore, in vitro evidence suggested that vancomycin-associated endothelial damage is caused by factors other than pH.
One randomized controlled trial found that the incidence of total complications, phlebitis, and thrombosis did not significantly differ when vancomycin was administered for less than 6 days via midline catheter versus PICC.
Conclusion Midline catheters have properties unique from those of peripheral and central VADs. Am J Infect Control. Antimicrobial dressings for the prevention of catheter-related infections in newborn infants with central venous catheters. Cochrane Database Syst Rev. PubMed Google Scholar. Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology for venous catheter placement and maintenance.
J Vasc Interv Radiol. The long-term effect of bundle care for catheter-related blood stream infection: 5-year follow-up. Postgrad Med J. Late onset sepsis in newborn babies: epidemiology and effect of a bundle to prevent central line associated bloodstream infections in the neonatal intensive care unit.
Braz J Infect Dis. Implementing a daily maintenance care bundle to prevent central line-associated bloodstream infections in pediatric oncology patients. J Pediatr Oncol Nurs.
Peripherally inserted central venous catheter-associated complications exert negative effects on body weight gain in neonatal intensive care units. Asia Pac J Clin Nutr. Incidence and factors associated with nosocomial infections in a neonatal intensive care unit NICU of an urban children's hospital in China.
Clin Exp Obstet Gynecol. Biofilm-based central line-associated bloodstream infections. Adv Exp Med Biol. Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. J Chemother. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
J Hosp Infect. Usefulness of anti-infective lock solutions for catheter-related bloodstream infections. Mt Sinai J Med. Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin.
Int Urol Nephrol. Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in children.
A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial.
Pediatr Crit Care Med. Management of neonates with suspected or proven early-onset bacterial sepsis. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial NeoPIns.
Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study.
Semin Dial. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients. Clin J Am Soc Nephrol. Percival SL, Kite P. Intravascular catheters and biofilm control. J Vasc Access. Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections.
Infect Drug Resist. Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection. J Antimicrob Chemother. Synergy of ambroxol with vancomycin in elimination of catheter-related Staphylococcus epidermidis biofilm in vitro and in vivo. J Infect Chemother. J Pediatr Pharmacol Ther. Clinical utility and safety of a model-based patient-tailored dose of Vancomycin in neonates.
Antimicrob Agents Chemother. He has spent over 20 years working in the market research industry. Get the latest industry news and expert insights delivered straight to your inbox!
Sign in or Sign-up. Guest Column May 31, Vascular Access Device Market. By Kamran Zamanian, Ph. Expanding Competitive Landscape C. About iData Research iData Research is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. Resources U. Accessed May 2, Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: Epidemiologic and economic consequences.
American Journal of Infection Control. Mayo Clinic Proceedings.
0コメント